The use of hydroxychloroquine (HCL) has been very common in countries with a rapid spread of coronavirus disease 2019 (COVID-19), although controversial and the subject of heated scientific discussions with implications for the whole society. This article is protected by copyright. All rights reserved.
Lucchesi, A., Silimbani, P., Musuraca, G., Cerchione, C., Martinelli, G., Di Carlo, P., et al. (2020). Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease. JOURNAL OF MEDICAL VIROLOGY [10.1002/jmv.26217].
Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease
Di Carlo, PaolaConceptualization
;Napolitano, MariasantaWriting – Review & Editing
2020
Abstract
The use of hydroxychloroquine (HCL) has been very common in countries with a rapid spread of coronavirus disease 2019 (COVID-19), although controversial and the subject of heated scientific discussions with implications for the whole society. This article is protected by copyright. All rights reserved.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Accepted article.pdf
non disponibili
Descrizione: Articolo accettato e rivisto
Tipologia:
Pre-print
Dimensione
295.36 kB
Formato
Adobe PDF
|
295.36 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
